Company
OrsoBio
| Industry | clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| OrsoBio | Series B Financing | 2024-09-09 |
| OrsoBio | Series A Financing | 2023-11-07 |
Company
| Industry | clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders |
|---|
| Company | Round | Date |
|---|---|---|
| OrsoBio | Series B Financing | 2024-09-09 |
| OrsoBio | Series A Financing | 2023-11-07 |